PracticeUpdate: Conference Series | ADC 2018

First page Table of contents Previous page 3 Next page Last page

PracticeUpdate is guided by a world-renowned Editorial and Advisory Board that represents community practitioners and academic specialists with cross-disciplinary expertise. Editor-in-Chief Silvio Inzucchi MD Associate Editors Richard Pratley MD, Deborah Wexler MD, MSc Advisory Board Kathleen Dungan MD, MPH , Peter Libby MD Benjamin Morgan Scirica MD Editorial Contributors Anika Anam MD, Ana Perdigoto MD, PhD Jason Sloane MD

For a complete listing of disclosures for each board member and editorial contributor, please refer to their profile on PracticeUpdate.com PracticeUpdate ’s mission is to help medical professionals navigate the vast array of available literature and focus on the most critical information for their patients and practice. PracticeUpdate Conference Series is a collection of key research from leading international conferences, reviewed by the PracticeUpdate editorial and advisory board, made available in print format. These news highlights and more are also available online at PracticeUpdate.com PracticeUpdate and the PracticeUpdate Conference Series are commercially supported by advertising, sponsorship, and educational grants. Individual access to PracticeUpdate.com is free. Premium content is available to any user who registers with the site. While PracticeUpdate is a commercially-sponsored product, it maintains the highest level of academic rigour, objectivity, and fair balance associated with all Elsevier products. No editorial content is influenced in any way by commercial sponsors or content contributors. DISCLAIMER The PracticeUpdate Conference Series provides highlights of key international conferences for specialist medical professionals. The ideas and opinions expressed in this publication do not necessarily reflect those of the Publisher. Elsevier will not assume responsibility for damages, loss, or claims of any kind arising from or related to the informationcontained in thispublication, includinganyclaimsrelated to the products, drugs, or services mentioned herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Please consult the full current Product Information before prescribing any medication mentioned in this publication. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. The production and distribution of this publication is sponsored by MSD Australia. It contains content published in accordance with the editorial policies of Elsevier’s PracticeUpdate.com. Content was produced by Elsevier with no involvement by MSD Australia. All content printed in this publication can be found on PracticeUpdate.com SALES Fleur Gill fleur.gill@elsevier.com Matthew Buttsworth m.buttsworth@elsevier.com Linnea Mitchell-Taverner l.mitchell@elsevier.com PRODUCTION Content was originally published on PracticeUpdate.com Production of this issue was executed by: Editorial Manager A nne Neilson anne.neilson@elsevier.com Editorial Project Manager Carolyn Ng Designer Jana Sokolovskaja ISSN 2208-150X (Print) • ISSN 2208-1518 (Online)

Contents

ADC 2018 • 22–24 August 2018 • Adelaide, South Australia

2 National Diabetes Registry to Analyze Clinical Benefits of Subsidized CGM By the PracticeUpdate Editorial Team Comment by Peter Colman MBBS, FRACP, MD 2 Australasian Diabetes Congress 2018 Highlights By Sof Andrikopoulos PhD , Louise Maple- Brown PhD & Josephine Forbes PhD 4 ‘Problematic Hypoglycemia in Adults With T1D Can Be Avoided’ By the PracticeUpdate Editorial Team 6 Can Oral Insulin Delay Progression to T1D? By the PracticeUpdate Editorial Team 7 Update on Intranasal Insulin Trial II (INIT II) to Prevent Type 1 Diabetes By the PracticeUpdate Editorial Team 8 Preventing Type 1 Diabetes: What We Know Interview with John Wentworth MBBS, PhD, FRACP 9 Once-Weekly Dulaglutide Noninferior to Once-Daily Liraglutide in Patients With Type 2 Diabetes By the PracticeUpdate Editorial Team

10 Is Targeting Mitochondrial Dysfunction Worth Considering as a Prevention Strategy for Kidney Disease in T1D? By the PracticeUpdate Editorial Team Comment by Josephine Forbes PhD 11 Clinical Islet Transplantation in Australia By Toby Coates MBBS, PhD, FRACP 12 Research Uncovers Potential Role of Gut Microbiome in T1D Pathogenesis By the PracticeUpdate Editorial Team 13 Biodegradable Temporising Matrix as an Alternative Intracutaneous Site for Islet Transplantation By Toby Coates MBBS, PhD, FRACP & John Greenwood MBCHB, MD, DHLTHSC, FRCS(ENG), FRCS(PLAST), FRACS 14 CVD-REAL 2: SGLT2 Inhibitors Associated With Lower CV Risk vs Other Glucose- Lowering Drugs By the PracticeUpdate Editorial Team 15 Adding Liraglutide to Standard of Care Lowers Risk of Glycemic Deterioration in T2D Patients at High CV Risk By the PracticeUpdate Editorial Team 16 ‘There Is More to Neuropathy Than Hyperglycemia Alone in T2D’ By the PracticeUpdate Editorial Team Comment by Josephine Forbes PhD

ELSEVIER AUSTRALIA ABN 70 001 002 357 475 Victoria Avenue Chatswood NSW 2067 Australia Locked Bag 7500 Chatswood DC NSW 2067 Printed in Australia. EMCS101804

ADC 2018 • PRACTICEUPDATE CONFERENCE SERIES

Made with FlippingBook - Online Brochure Maker